List of Tables
Table 1. Global PD-1 and PD-L1 Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global PD-1 and PD-L1 Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global PD-1 and PD-L1 Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global PD-1 and PD-L1 Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global PD-1 and PD-L1 Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global PD-1 and PD-L1 Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global PD-1 and PD-L1 Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market PD-1 and PD-L1 Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of PD-1 and PD-L1 Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of PD-1 and PD-L1 Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PD-1 and PD-L1 Drug, Product Type & Application
Table 12. Global Key Manufacturers of PD-1 and PD-L1 Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PD-1 and PD-L1 Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-1 and PD-L1 Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PD-1 and PD-L1 Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global PD-1 and PD-L1 Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global PD-1 and PD-L1 Drug Sales Market Share by Region (2019-2024)
Table 19. Global PD-1 and PD-L1 Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global PD-1 and PD-L1 Drug Sales Market Share by Region (2025-2030)
Table 21. Global PD-1 and PD-L1 Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global PD-1 and PD-L1 Drug Revenue Market Share by Region (2019-2024)
Table 23. Global PD-1 and PD-L1 Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global PD-1 and PD-L1 Drug Revenue Market Share by Region (2025-2030)
Table 25. North America PD-1 and PD-L1 Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America PD-1 and PD-L1 Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America PD-1 and PD-L1 Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America PD-1 and PD-L1 Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America PD-1 and PD-L1 Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe PD-1 and PD-L1 Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe PD-1 and PD-L1 Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe PD-1 and PD-L1 Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe PD-1 and PD-L1 Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe PD-1 and PD-L1 Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific PD-1 and PD-L1 Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific PD-1 and PD-L1 Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific PD-1 and PD-L1 Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific PD-1 and PD-L1 Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific PD-1 and PD-L1 Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America PD-1 and PD-L1 Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America PD-1 and PD-L1 Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America PD-1 and PD-L1 Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America PD-1 and PD-L1 Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America PD-1 and PD-L1 Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa PD-1 and PD-L1 Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa PD-1 and PD-L1 Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa PD-1 and PD-L1 Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa PD-1 and PD-L1 Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa PD-1 and PD-L1 Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global PD-1 and PD-L1 Drug Sales (K Units) by Type (2019-2024)
Table 51. Global PD-1 and PD-L1 Drug Sales (K Units) by Type (2025-2030)
Table 52. Global PD-1 and PD-L1 Drug Sales Market Share by Type (2019-2024)
Table 53. Global PD-1 and PD-L1 Drug Sales Market Share by Type (2025-2030)
Table 54. Global PD-1 and PD-L1 Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global PD-1 and PD-L1 Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global PD-1 and PD-L1 Drug Revenue Market Share by Type (2019-2024)
Table 57. Global PD-1 and PD-L1 Drug Revenue Market Share by Type (2025-2030)
Table 58. Global PD-1 and PD-L1 Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global PD-1 and PD-L1 Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global PD-1 and PD-L1 Drug Sales (K Units) by Application (2019-2024)
Table 61. Global PD-1 and PD-L1 Drug Sales (K Units) by Application (2025-2030)
Table 62. Global PD-1 and PD-L1 Drug Sales Market Share by Application (2019-2024)
Table 63. Global PD-1 and PD-L1 Drug Sales Market Share by Application (2025-2030)
Table 64. Global PD-1 and PD-L1 Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global PD-1 and PD-L1 Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global PD-1 and PD-L1 Drug Revenue Market Share by Application (2019-2024)
Table 67. Global PD-1 and PD-L1 Drug Revenue Market Share by Application (2025-2030)
Table 68. Global PD-1 and PD-L1 Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global PD-1 and PD-L1 Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Bristol Myers Squibb Corporation Information
Table 71. Bristol Myers Squibb Description and Business Overview
Table 72. Bristol Myers Squibb PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Bristol Myers Squibb PD-1 and PD-L1 Drug Product
Table 74. Bristol Myers Squibb Recent Developments/Updates
Table 75. Merck & Co., Inc. Corporation Information
Table 76. Merck & Co., Inc. Description and Business Overview
Table 77. Merck & Co., Inc. PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Merck & Co., Inc. PD-1 and PD-L1 Drug Product
Table 79. Merck & Co., Inc. Recent Developments/Updates
Table 80. F. Hoffmann -La Roche Ltd Corporation Information
Table 81. F. Hoffmann -La Roche Ltd Description and Business Overview
Table 82. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Product
Table 84. F. Hoffmann -La Roche Ltd Recent Developments/Updates
Table 85. AstraZeneca Corporation Information
Table 86. AstraZeneca Description and Business Overview
Table 87. AstraZeneca PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. AstraZeneca PD-1 and PD-L1 Drug Product
Table 89. AstraZeneca Recent Developments/Updates
Table 90. Sanofi Corporation Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sanofi PD-1 and PD-L1 Drug Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Pfizer Inc Corporation Information
Table 96. Pfizer Inc Description and Business Overview
Table 97. Pfizer Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Pfizer Inc PD-1 and PD-L1 Drug Product
Table 99. Pfizer Inc Recent Developments/Updates
Table 100. Lilly Corporation Information
Table 101. Lilly Description and Business Overview
Table 102. Lilly PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Lilly PD-1 and PD-L1 Drug Product
Table 104. Lilly Recent Developments/Updates
Table 105. Novartis AG Corporation Information
Table 106. Novartis AG Description and Business Overview
Table 107. Novartis AG PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Novartis AG PD-1 and PD-L1 Drug Product
Table 109. Novartis AG Recent Developments/Updates
Table 110. GSK Corporation Information
Table 111. GSK Description and Business Overview
Table 112. GSK PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. GSK PD-1 and PD-L1 Drug Product
Table 114. GSK Recent Developments/Updates
Table 115. Junshi Biosciences Corporation Information
Table 116. Junshi Biosciences Description and Business Overview
Table 117. Junshi Biosciences PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Junshi Biosciences PD-1 and PD-L1 Drug Product
Table 119. Junshi Biosciences Recent Developments/Updates
Table 120. Akeso, Inc Corporation Information
Table 121. Akeso, Inc Description and Business Overview
Table 122. Akeso, Inc PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Akeso, Inc PD-1 and PD-L1 Drug Product
Table 124. Akeso, Inc Recent Developments/Updates
Table 125. BeiGene Corporation Information
Table 126. BeiGene Description and Business Overview
Table 127. BeiGene PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. BeiGene PD-1 and PD-L1 Drug Product
Table 129. BeiGene Recent Developments/Updates
Table 130. Innovent Corporation Information
Table 131. Innovent Description and Business Overview
Table 132. Innovent PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Innovent PD-1 and PD-L1 Drug Product
Table 134. Innovent Recent Developments/Updates
Table 135. Jiangsu Hengrui Medicine Co.,Ltd Corporation Information
Table 136. Jiangsu Hengrui Medicine Co.,Ltd Description and Business Overview
Table 137. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Product
Table 139. Jiangsu Hengrui Medicine Co.,Ltd Recent Developments/Updates
Table 140. Cstone Corporation Information
Table 141. Cstone Description and Business Overview
Table 142. Cstone PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Cstone PD-1 and PD-L1 Drug Product
Table 144. Cstone Recent Developments/Updates
Table 145. Henlius Corporation Information
Table 146. Henlius Description and Business Overview
Table 147. Henlius PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Henlius PD-1 and PD-L1 Drug Product
Table 149. Henlius Recent Developments/Updates
Table 150. Simcere Pharmaceutical Group Limited Corporation Information
Table 151. Simcere Pharmaceutical Group Limited Description and Business Overview
Table 152. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Product
Table 154. Simcere Pharmaceutical Group Limited Recent Developments/Updates
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. PD-1 and PD-L1 Drug Distributors List
Table 158. PD-1 and PD-L1 Drug Customers List
Table 159. PD-1 and PD-L1 Drug Market Trends
Table 160. PD-1 and PD-L1 Drug Market Drivers
Table 161. PD-1 and PD-L1 Drug Market Challenges
Table 162. PD-1 and PD-L1 Drug Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PD-1 and PD-L1 Drug
Figure 2. Global PD-1 and PD-L1 Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global PD-1 and PD-L1 Drug Market Share by Type in 2023 & 2030
Figure 4. PD-1 Monoclonal Antibody Product Picture
Figure 5. PD-L1 Monoclonal Antibody Product Picture
Figure 6. Global PD-1 and PD-L1 Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global PD-1 and PD-L1 Drug Market Share by Application in 2023 & 2030
Figure 8. Liver Cancer
Figure 9. Esophageal Cancer
Figure 10. Nasal Cancer
Figure 11. Stomach Cancer
Figure 12. Other
Figure 13. Global PD-1 and PD-L1 Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global PD-1 and PD-L1 Drug Market Size (2019-2030) & (US$ Million)
Figure 15. Global PD-1 and PD-L1 Drug Sales (2019-2030) & (K Units)
Figure 16. Global PD-1 and PD-L1 Drug Average Price (US$/Unit) & (2019-2030)
Figure 17. PD-1 and PD-L1 Drug Report Years Considered
Figure 18. PD-1 and PD-L1 Drug Sales Share by Manufacturers in 2023
Figure 19. Global PD-1 and PD-L1 Drug Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest PD-1 and PD-L1 Drug Players: Market Share by Revenue in 2023
Figure 21. PD-1 and PD-L1 Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global PD-1 and PD-L1 Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America PD-1 and PD-L1 Drug Sales Market Share by Country (2019-2030)
Figure 24. North America PD-1 and PD-L1 Drug Revenue Market Share by Country (2019-2030)
Figure 25. United States PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe PD-1 and PD-L1 Drug Sales Market Share by Country (2019-2030)
Figure 28. Europe PD-1 and PD-L1 Drug Revenue Market Share by Country (2019-2030)
Figure 29. Germany PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific PD-1 and PD-L1 Drug Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific PD-1 and PD-L1 Drug Revenue Market Share by Region (2019-2030)
Figure 36. China PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America PD-1 and PD-L1 Drug Sales Market Share by Country (2019-2030)
Figure 44. Latin America PD-1 and PD-L1 Drug Revenue Market Share by Country (2019-2030)
Figure 45. Mexico PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa PD-1 and PD-L1 Drug Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa PD-1 and PD-L1 Drug Revenue Market Share by Country (2019-2030)
Figure 50. Turkey PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE PD-1 and PD-L1 Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of PD-1 and PD-L1 Drug by Type (2019-2030)
Figure 54. Global Revenue Market Share of PD-1 and PD-L1 Drug by Type (2019-2030)
Figure 55. Global PD-1 and PD-L1 Drug Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of PD-1 and PD-L1 Drug by Application (2019-2030)
Figure 57. Global Revenue Market Share of PD-1 and PD-L1 Drug by Application (2019-2030)
Figure 58. Global PD-1 and PD-L1 Drug Price (US$/Unit) by Application (2019-2030)
Figure 59. PD-1 and PD-L1 Drug Value Chain
Figure 60. PD-1 and PD-L1 Drug Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
